Stories
Slash Boxes
Comments

SoylentNews is people

posted by chromas on Wednesday January 23 2019, @10:24AM   Printer-friendly
from the stop-being-poor dept.

U.S. insulin costs per patient nearly doubled from 2012 to 2016, study finds

The cost of insulin for treating Type 1 diabetes in the United States nearly doubled over a recent five-year period, underscoring a national outcry over rising drug prices, according to a new analysis.

A patient with Type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was roughly half that, at $2,864 per patient, in 2012, according to a report released on Tuesday by the nonprofit Health Care Cost Institute.

The figures represent the combined amount paid by a patient and their health plan for the medicine and do not reflect rebates paid at a later date.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by dry on Thursday January 24 2019, @06:33AM (1 child)

    by dry (223) on Thursday January 24 2019, @06:33AM (#791092) Journal

    You still get the exploitative pharmaceutical industry, though you might have the buying power to make a difference. Here in Canada, drugs cost a fortune as each Province/Territory negotiates separately.

    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2  
  • (Score: 2) by PartTimeZombie on Thursday January 24 2019, @06:34PM

    by PartTimeZombie (4827) on Thursday January 24 2019, @06:34PM (#791357)

    That's true, they are exploitative. We have a national drug buying agency, and surprise surprise our American friends were very keen to hobble it during the TPP negotiations.